Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020

This statistic shows the percentage of U.S. health care executives who foresee biosimilars reducing drug spend for specialty drugs in 2017 to 2020. Nearly nine percent of executives stated they think drug spending reduction due to biosimilars will come into effect in 2017, while 25 percent think it will happen in 2020.

Percentage of U.S. health care executives who foresee biosimilars reducing drug spend for specialty drugs in 2017-2020*

Percentage of respondents
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2018

Region

United States

Survey time period

as of December 2015

Number of respondents

228 respondents

Special properties

executives involved in health care industry

Supplementary notes

* Executives at medical practices, hospitals, large healthcare systems, benefit management organizations, health plans, long-term care organizations, group purchasing organizations and consulting firms.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.